Facile Synthesis of Ureidic Derivatives of Betulinic Acid With Antiproliferative Effects on Colorectal and Prostate Cancer Cells
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Betulinic acid derivatives were synthesized and tested for anti-cancer effects. Compound BA1 showed potent activity against colon and prostate cancer cells, demonstrating anti-proliferative and anti-metastatic properties.
Area Of Science
- Natural Product Chemistry
- Medicinal Chemistry
- Cancer Biology
Background
- Betulinic acid, a natural compound from Platanus orientalis bark, is a precursor for novel anti-cancer agents.
- Ureidic derivatives of betulinic acid were explored for enhanced therapeutic potential.
Purpose Of The Study
- To synthesize novel ureidic derivatives of betulinic acid.
- To evaluate the anti-cancer activity of these derivatives against various human cancer cell lines.
- To investigate the mechanism of action, including apoptosis induction.
Main Methods
- One-pot synthesis of 12 ureidic derivatives from betulinic acid.
- In vitro anti-cancer activity screening against colon (HCT-116), breast (MCF-7), pancreatic (MIA PaCa-2), and prostate (PC-3) cancer cell lines.
- Determination of IC50 values and comparison with doxorubicin standard.
Main Results
- Twelve ureidic derivatives of betulinic acid were successfully synthesized.
- Compound BA1 demonstrated significant anti-cancer activity with IC50 values of 0.84 µM against HCT-116 and 3.87 µM against PC-3.
- BA1 exhibited anti-proliferative and anti-metastatic effects, inducing apoptosis in prostate and colorectal cancer cells.
Conclusions
- Betulinic acid derivatives, particularly BA1, hold promise as novel anti-cancer therapeutics.
- BA1's potent activity and apoptosis-inducing mechanism warrant further investigation for prostate and colorectal cancer treatment.
- The study highlights the potential of modifying natural products for drug discovery.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...